Skip to content
AnalystLens

Tenet Healthcare Annual Report, Year Ended Dec 31, 2003

Filing Date
Filed March 15, 2004
Period End
December 31, 2003
Security
THC
In the record · 2016–202610-K1110-Q338-K176

THC filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 176 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jan ’18Jan ’18
  2. Material agreement8-K · Sep ’19Sep ’19
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Leadership change8-K · Nov ’25Nov ’25

Summary

Summary of the 10-K filed March 15, 2004. Cited figures are marked; the original filing is the authoritative source.

Tenet Healthcare Corporation's 10-K for the fiscal year ended December 31, 2003 reports a sharp deterioration in results.

Net operating revenues were $13.21 billiona in 2003, compared with $13.60 billion in the year ended December 31, 2002 (unaudited). The company reported a loss from continuing operations of $1.40 billion, or $3.01 per diluted share, versus income of $744 million in 2002. Net loss was $1.48 billion.

The loss was driven largely by $1.88 billionb of impairment and restructuring charges (including $1.12 billion of goodwill impairment) and $282 million of costs of litigation and investigations. Medicare outlier revenue fell from approximately $750 million in 2002 to approximately $140 million in 2003, and the provision for doubtful accounts rose to $1.44 billion from $969 million, reflecting growth in uninsured and self-pay admissions. Cash flow from operations fell to $838 million from $2.33 billion in the comparable 2002 period.

Unrestricted cash was about $600 millionc at year-end, and the company said it has no significant debt maturities before late 2006. Management stated that it does not expect significant operating or margin improvement in 2004 and, potentially, 2005. To address these issues, Tenet announced in January 2004 the proposed divestiture of 27 hospitals, leaving a core group of 69 domestic hospitals, and expects net proceeds of about $600 million, largely in tax benefits it does not expect to realize until 2005.

The credit agreement was amended in March 2004, reducing commitments from $1.2 billion to $800 milliond and loosening the maximum leverage ratio to 5.5-to-1 through June 30, 2005. The filing also discloses extensive government investigations and litigation, including the Redding Medical Center matters, Medicare coding and transfer-discharge investigations, pricing class actions, securities class actions, and an SEC formal investigation.

The company states that these matters could have a material adverse effect on its business, financial position, results of operations or cash flows. A $148 million California judgment (paid as $163.3 million in March 2004) and an IRS proposed deficiency of $157 million plus about $122 million of interest are also described.

Key Highlights

  1. Net operating revenues of $13.21 billion for 2003, down from $13.60 billion in the year ended December 31, 2002.
  2. Net loss of $1.48 billion for 2003, including a loss from continuing operations of $1.40 billion, or $3.01 per diluted share, versus income from continuing operations of $744 million in 2002.
  3. Impairment and restructuring charges of $1.88 billion in 2003, including $1.12 billion of goodwill impairment, plus $282 million of costs of litigation and investigations.
  4. Medicare outlier revenue dropped from approximately $750 million in 2002 to approximately $140 million in 2003, and provision for doubtful accounts rose to $1.44 billion from $969 million.
  5. Net cash provided by operating activities fell to $838 million from $2.33 billion in the comparable 2002 period; unrestricted cash was about $600 million at December 31, 2003.
  6. Announced the proposed divestiture of 27 hospitals in January 2004, with expected net proceeds of about $600 million, leaving 69 core domestic hospitals.
  7. Amended bank credit agreement in March 2004: commitments reduced from $1.2 billion to $800 million, with the maximum leverage ratio raised to 5.5-to-1 through June 30, 2005.

Frequently Asked Questions

  1. Why did Tenet report such a large loss in 2003?

    The loss was primarily driven by $1.88 billion of impairment and restructuring charges, of which $1.12 billion was goodwill impairment, along with $282 million of costs of litigation and investigations and a $198 million additional charge to the provision for doubtful accounts. Lower Medicare outlier revenue, which fell from about $750 million to about $140 million, also reduced revenues.

  2. What is driving the decline in revenue and cash flow?

    The filing cites reduced Medicare outlier revenue following changes to its outlier calculation and CMS rules, continued growth in routine costs such as labor, rising bad-debt expense from more uninsured and underinsured patients, and costs of litigation and investigations. Net cash from operations fell to $838 million from $2.33 billion.

  3. What is Tenet doing to improve its financial position?

    Tenet announced plans to divest 27 hospitals, focusing on 69 core domestic hospitals, and expects about $600 million in net proceeds, much of it in tax benefits expected in 2005. It is also reducing costs, implementing a discount plan for uninsured patients, consolidating business offices, and forming a new compliance department. Management does not expect significant margin improvement in 2004 and potentially 2005.

  4. What are the main legal and regulatory risks disclosed?

    The filing describes numerous government investigations and lawsuits, including physician relationship probes, Medicare outlier and coding inquiries, pricing class actions, securities and shareholder suits, an SEC formal investigation, and the Redding Medical Center matters. The company states these could have a material adverse effect on its business, financial position, results of operations or cash flows, and it notes an IRS proposed tax deficiency of $157 million plus about $122 million of interest.